Sections
Title | Starting Page | Number of Pages |
---|
Table of Contents | 2 | 4 |
List of Tables | 4 | 1 |
List of Figures | 5 | 1 |
Section 1 - About the Company | 5 | 1 |
NanoString Technologies Inc - Key Facts | 6 | 1 |
NanoString Technologies Inc - Key Employees | 7 | 1 |
NanoString Technologies Inc - Major Products and Services | 8 | 1 |
NanoString Technologies Inc - Medical Equipment Pipeline Products Data | 9 | 3 |
NanoString Technologies Inc Pipeline Products by Equipment Type | 9 | 1 |
NanoString Technologies Inc Pipeline Products by Development Stage | 10 | 2 |
NanoString Technologies Inc - History | 12 | 2 |
NanoString Technologies Inc - Locations And Subsidiaries | 14 | 1 |
Head Office | 14 | 1 |
Section 2 Company Analysis | 15 | 1 |
Company Overview | 15 | 1 |
NanoString Technologies Inc - Key Competitors | 16 | 1 |
Section 3 Company Financial Ratios | 17 | 1 |
Financial Ratios - Capital Market Ratios | 17 | 1 |
Financial Ratios - Annual Ratios | 18 | 2 |
Performance Chart | 20 | 1 |
Financial Performance | 20 | 1 |
Financial Ratios - Interim Ratios | 21 | 1 |
Financial Ratios - Ratio Charts | 22 | 1 |
Section 4 Company s Lifesciences Financial Deals and Alliances | 23 | 4 |
NanoString Technologies Inc, Medical Equipment, Deals By Year, 2010 to YTD 2016 | 23 | 1 |
NanoString Technologies Inc, Medical Equipment, Deals By Type, 2010 to YTD 2016 | 24 | 1 |
NanoString Technologies Inc, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 25 | 1 |
NanoString Technologies Inc, Pharmaceuticals &Healthcare, Deals By Type, 2010 to YTD 2016 | 26 | 1 |
NanoString Technologies Inc, Recent Deals Summary | 27 | 1 |
Section 5 Company s Recent Developments | 28 | 1 |
Nov 18, 2016: NanoString Enhances Solid Tumor Profiling with 3D Biology Capabilities for Formalin-Fixed, Paraffin-Embedded (FFPE) Tissue Samples | 28 | 1 |
Nov 07, 2016: NanoString Launches Technology Access Program (TAP) for Transformative Platform for High-Plex Digital Spatial Profiling | 29 | 1 |
Nov 02, 2016: NanoString Technologies Releases Operating Results for Third Quarter of 2016 | 30 | 1 |
Sep 13, 2016: NanoString Technologies Appoints Kirk Malloy, Ph.D. to Board of Directors | 31 | 1 |
Aug 03, 2016: NanoString Technologies Releases Operating Results for Second Quarter of 2016 | 32 | 1 |
Jun 02, 2016: NanoString Technologies Highlights Advances in Precision Oncology and Immunotherapy at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) | 33 | 3 |
May 05, 2016: NanoString Technologies Releases Operating Results for First Quarter of 2016 | 36 | 1 |
Apr 14, 2016: NanoString Technologies Unveils New nCounter Vantage Assays to Power Cancer Research With 3D Biology | 37 | 1 |
Feb 29, 2016: NanoString Technologies Releases Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Outlook | 38 | 2 |
Feb 09, 2016: American Society of Clinical Oncology Clinical Practice Guideline Recommends Use of Prosigna (PAM50) for Guiding Treatment Decisions in Early Stage Breast Cancer Patients | 40 | 1 |
Section 6 Appendix | 41 | 5 |
Methodology | 41 | 1 |
Ratio Definitions | 41 | 4 |
About GlobalData | 45 | 1 |
Contact Us | 45 | 1 |
Disclaimer | 45 | 1 |